UK Court of Appeal Upholds Moderna mRNA Patent Against Pfizer/BioNTech

Start
On August 1, 2025, a UK Court of Appeal upheld the validity of Moderna’s European Patent No. 3,590,949 (“EP’949”) in a dispute with Pfizer and BioNTech. The decision affirmed a July 2024 UK High Court ruling finding that EP’949 is both valid and infringed by Pfizer/BioNTech’s COVID-19 vaccine, Comirnaty®….
By: Goodwin
Previous Story

5 Pitfalls Of Delaying Automation In High-Volume Litigation And Claims

Next Story

When AI Conversations Become Compliance Risks: Rethinking Confidentiality in the ChatGPT Era